Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
xonvea magasýruþolin tafla 10 mg/10 mg
campuspharma ab - pyridoxinum hýdróklóríð; doxylaminii hýdrógen súkkínat - magasýruþolin tafla - 10 mg/10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
chanazine 10%, vet. stungulyf, lausn 10 %
chanelle pharmaceuticals manufacturing ltd* - xylazinum inn - stungulyf, lausn - 10 %
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
chanazine 2%, vet. stungulyf, lausn 2 %
chanelle pharmaceuticals manufacturing ltd* - xylazinum inn - stungulyf, lausn - 2 %
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nerfasin vet. stungulyf, lausn 100 mg/ml
le vet b.v.* - xylazinum hýdróklóríð - stungulyf, lausn - 100 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nerfasin vet. stungulyf, lausn 20 mg/ml
le vet b.v.* - xylazinum hýdróklóríð - stungulyf, lausn - 20 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
rompun vet. stungulyf, lausn 20 mg/ml
elanco animal health gmbh - xylazinum hýdróklóríð - stungulyf, lausn - 20 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
dropizol (dropium) dropar til inntöku, lausn 10 mg/ml
pharmanovia a/s - opium - dropar til inntöku, lausn - 10 mg/ml
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
wakix
bioprojet pharma - pitolisant - narcolepsy - Önnur lyf í taugakerfinu - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - Önnur lyf í taugakerfinu - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).